Press releases
- Masimo to Present in BofA Securities Health Care Conference
- Masimo Reports First Quarter 2024 Financial Results
- Masimo Receives FDA Clearance for Stork™ Over-the-Counter (OTC) Baby Monitoring System
- Masimo to Report First Quarter 2024 Financial Results after Market Close on Tuesday, May 7
- Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile
- Masimo Responds to Politan Capital’s Nomination of Director Candidates and Refutes Politan’s False Claims
- Politan Nominates Two Independent Candidates for Masimo Board
- Masimo Corporation Board of Directors Authorizes Management to Evaluate the Separation of Consumer Business
- Masimo Named One of Fast Company’s Most Innovative Companies in North America
- Masimo Celebrates Multiple Wins at the iF DESIGN AWARDS 2024
More ▼
Key statistics
On Friday, Masimo Corp (M2AS34:SAO) closed at 20.68, 33.76% above the 52 week low of 15.46 set on Nov 22, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 21.25 |
---|---|
High | 21.25 |
Low | 20.68 |
Bid | 20.94 |
Offer | 24.00 |
Previous close | 21.25 |
Average volume | 588.90 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of May 10 2024 20:54 BST.
More ▼